Previous close | 39.35 |
Open | 45.95 |
Bid | 45.75 |
Ask | 48.05 |
Strike | 900.00 |
Expiry date | 2024-08-09 |
Day's range | 43.57 - 45.95 |
Contract range | N/A |
Volume | |
Open interest | 36 |
Tesla drove the S&P 500 and Nasdaq to highs, though small caps fell for the week. Cooling economic data raised rate-cut hopes.
Eli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi (SNY) and Regeneron's Dupixent gets approval for COPD in Europe.
A new study led by investigators of a Harvard-affiliated teaching hospital found that Novo Nordisk's (NVO) GLP-1 drugs Ozempic and Wegovy could be linked to rare cases of vision loss.